XML 101 R44.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Earnings Per Common Share Attributable to Pfizer Inc. Common Shareholders (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2018
Earnings Per Share [Abstract] |
Schedule of Basic and Diluted Earning Per Share |
The following table provides the detailed calculation of Earnings per common share (EPS):
|  | Year Ended December 31,
(IN MILLIONS) |  | 2018 |  |  | 2017 |  |  | 2016 |
EPS Numerator––Basic |  |  |  |  |  |  |
Income from continuing operations |  | $ | 11,179 |  |  | $ | 21,353 |  |  | $ | 7,229 |
Less: Net income attributable to noncontrolling interests |  | 36 |  |  | 47 |  |  | 31 |
Income from continuing operations attributable to Pfizer Inc. |  | 11,143 |  |  | 21,306 |  |  | 7,198 |
Less: Preferred stock dividends––net of tax |  | 1 |  |  | 1 |  |  | 1 |
Income from continuing operations attributable to Pfizer Inc. common shareholders |  | 11,142 |  |  | 21,305 |  |  | 7,197 |
Discontinued operations––net of tax |  | 10 |  |  | 2 |  |  | 17 |
Less: Discontinued operations––net of tax, attributable to noncontrolling interests |  | — |  |  | — |  |  | — |
Discontinued operations––net of tax, attributable to Pfizer Inc. common shareholders |  | 10 |  |  | 2 |  |  | 17 |
Net income attributable to Pfizer Inc. common shareholders |  | $ | 11,152 |  |  | $ | 21,307 |  |  | $ | 7,214 |
EPS Numerator––Diluted |  |  |  |  |  |  |  |
Income from continuing operations attributable to Pfizer Inc. common shareholders and assumed conversions |  | $ | 11,143 |  |  | $ | 21,306 |  |  | $ | 7,197 |
Discontinued operations––net of tax, attributable to Pfizer Inc. common shareholders and assumed conversions |  | 10 |  |  | 2 |  |  | 17 |
Net income attributable to Pfizer Inc. common shareholders and assumed conversions |  | $ | 11,153 |  |  | $ | 21,308 |  |  | $ | 7,214 |
EPS Denominator |  |  |  |  |  |  |  |
Weighted-average number of common shares outstanding––Basic(a) |  | 5,872 |  |  | 5,970 |  |  | 6,089 |
Common-share equivalents: stock options, stock issuable under employee compensation plans, convertible preferred stock and accelerated share repurchase agreements(a) |  | 105 |  |  | 89 |  |  | 70 |
Weighted-average number of common shares outstanding––Diluted |  | 5,977 |  |  | 6,058 |  |  | 6,159 |
Stock options that had exercise prices greater than the average market price of our common stock issuable under employee compensation plans(b) |  | 2 |  |  | 36 |  |  | 63 |
Cash dividends declared per share |  | $ | 1.38 |  |  | $ | 1.30 |  |  | $ | 1.22 |
(a) | 2017 includes the effect of the modification for a commitment to pay 15.2 million common-share equivalents that were scheduled for near-term settlement. These common share equivalents were paid in the first quarter of 2018.
(b) | These common stock equivalents were outstanding for the periods presented, but were not included in the computation of diluted EPS for those periods because their inclusion would have had an anti-dilutive effect.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration